Viewing Study NCT00601159


Ignite Creation Date: 2025-12-24 @ 2:45 PM
Ignite Modification Date: 2026-01-18 @ 3:12 PM
Study NCT ID: NCT00601159
Status: COMPLETED
Last Update Posted: 2011-07-04
First Post: 2007-12-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic Breast Cancer View
None triple-negative Breast Cancer View
None cisplatin View
None chemotherapy View